Opus Genetics Inc. has announced a management change with the departure of Chief Financial Officer Nirav Jhaveri. Amy Rabourn, currently the Senior Vice President of Finance, will serve as the interim principal financial officer and principal accounting officer until a successor is appointed. Rabourn, who has over 20 years of finance and accounting experience, joined Opus Genetics in November 2020 and was promoted to her current role in January 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.